Highland Capital Management (Texas)’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Highland Capital Management (Texas)’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$635K	Hold	68,700	–	–	0.04%	238
2019 Q1	$442K	Sell	68,700 -97,000	-59%	-$632K	0.03%	253
2018 Q4	$1.56M	Buy	165,700 +127,000	+328%	+$1.91M	0.12%	130
2018 Q3	$779K	Hold	38,700	–	–	0.04%	189
2018 Q2	$1.13M	Buy	38,700 +13,200	+52%	+$407K	0.06%	158
2018 Q1	$759K	Buy	+25,500	New	+$822K	0.04%	201
2017 Q2	–	Sell	-73,500	Closed	-$2.19M	–	384
2017 Q1	$2.19M	Buy	+73,500	New	+$1.88M	0.11%	150

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Highland Capital Management (Texas)'s LJPC Position: Q2 2019 in Review

Highland Capital Management (Texas) held its La Jolla Pharmaceutical Company (LJPC) position steady in Q2 2019 at 68,700 shares worth $635K. The position accounts for 0.04% of the portfolio, ranked #238.

Highland Capital Management (Texas) first reported a position in LJPC in Q1 2017 and has held it in 7 quarters since. The position peaked at $2.19M in Q1 2017. 80 funds tracked by Wall St. Rank hold LJPC as of Q2 2019.

Highland Capital Management (Texas) held 68,700 shares of La Jolla Pharmaceutical Company worth $635K as of Q2 2019.
Highland Capital Management (Texas) left its La Jolla Pharmaceutical Company share count unchanged in Q2 2019.
La Jolla Pharmaceutical Company made up 0.04% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #238 holding.
Highland Capital Management (Texas) first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and has held it in 7 quarters since.
Highland Capital Management (Texas)'s La Jolla Pharmaceutical Company position peaked at $2.19M in Q1 2017.
80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.